Company
Headquarters: Feldkirchen, Germany
Employees: 130
€136.9 Million
EUR as of July 1, 2024
US$147.0 Million
Company | Market Cap (USD) |
---|---|
Abbott | $178.02 B |
Stryker Corporation | $126.48 B |
Boston Scientific Corporation | $112.32 B |
Medtronic | $98.95 B |
Edwards Lifesciences Corporation | $55.63 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
PULSION Medical Systems SE engages in the development, manufacture, sale of monitoring, diagnosis, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include PiCCO2à, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlexà that offers technology in the field of perioperative medicine; PiCCOà, a catheter used to monitor the cardiovascular system; ProAQTà, a sensor used in medicine for high-risk patients and high-risk interventions; CeVOXà, a technology that enables continuous monitoring of the patient's oxygen balance; LiMONà, a technology used to assess and monitor liver function; NICCI for hemodynamic monitoring. The company was founded in 1990 and is based in Feldkirchen, Germany. PULSION Medical Systems SE was a former subsidiary of MAQUET GmbH
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Pulsion Medical Systems SE has the following listings and related stock indices.
Stock: Munich: PUS wb_incandescent